Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Procaps Group SA - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
PROC
Nasdaq
2834
https://www.procapsgroup.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Procaps Group SA
Procaps Group Announces Appointment of Jose Antonio Vieira as Chief Executive Officer Starting 2024
- Nov 22nd, 2023 1:30 pm
Procaps Group Update on Third Quarter Results
- Nov 14th, 2023 10:25 pm
Procaps Group to Report Third Quarter and Nine Months 2023 Results on Tuesday November 14, 2023
- Nov 10th, 2023 4:37 pm
Procaps Group Wins First Place in Ranking of Innovative Companies in the Pharma Sector in Colombia
- Oct 30th, 2023 12:30 pm
Procaps Appoints Sandra Sánchez y Oldenhage to Board of Directors
- Oct 23rd, 2023 9:01 pm
Procaps Group to Participate at CPHI Barcelona 2023
- Oct 16th, 2023 12:31 pm
Procaps Group to Host Webinar on Colombian Pharma Market
- Oct 2nd, 2023 12:00 pm
Procaps Group to Participate at BTG 2023 LatAm CEO Conference and Roth 2023 Healthcare Opportunities Conference in October
- Sep 15th, 2023 12:20 pm
Procaps Group Announces the Expansion of its Oncology Portfolio
- Sep 7th, 2023 12:30 pm
Procaps Group Reports Second Quarter 2023 Results
- Sep 5th, 2023 12:25 pm
Procaps Group to Report Second Quarter and First Half 2023 Results and Host Conference Call on Tuesday
- Aug 31st, 2023 10:35 pm
Procaps Group Publishes White Paper on Innovative Gummy Technology
- Aug 16th, 2023 12:31 pm
Procaps Group Reports First Quarter 2023 Results
- Jun 5th, 2023 11:45 pm
Procaps Group Reports Fourth Quarter and Full Year 2022 Results
- May 12th, 2023 9:30 pm
Financial Results and Business Update Conference Call to be Held May 2023 in Conjunction with 20-F Filing
- May 1st, 2023 12:17 pm
Procaps Issues Shareholder Letter and Provides Preliminary Fiscal Year 2022 Financial Results and 2023 Guidance
- Feb 13th, 2023 9:36 pm
Procaps Announces Key Changes to the Board of Directors
- Jan 19th, 2023 9:32 pm
Procaps Group Announces Termination of Acquisition Agreement with Grupo Somar
- Jan 3rd, 2023 9:13 pm
Procaps to Present at 2023 Annual J.P. Morgan Healthcare Conference
- Dec 29th, 2022 1:00 pm
Update on Proposed Acquisition of Grupo Somar
- Dec 22nd, 2022 9:02 pm
Scroll